UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bivalirudin for Patients with Acute Coronary Syndromes

The New England journal of medicine, 2006-11, Vol.355 (21), p.2203-2216

2006

Volltextzugriff (PDF)

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines

Journal of the American College of Cardiology, 2012-08, Vol.60 (7), p.645-681

2012

Volltextzugriff (PDF)

Intravenous Platelet Blockade with Cangrelor during PCI

The New England journal of medicine, 2009-12, Vol.361 (24), p.2330-2341

2009

Volltextzugriff (PDF)

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-01, Vol.311 (3), p.252

2014

Volltextzugriff (PDF)

Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

Circulation (New York, N.Y.), 2002-09, Vol.106 (10), p.1243-1250

2002

Volltextzugriff (PDF)

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

The American journal of cardiology, 2002-07, Vol.90 (1), p.42-45

2002

Volltextzugriff (PDF)

Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2009-05, Vol.53 (21), p.1965-1972

2009

Volltextzugriff (PDF)

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

JAMA : the journal of the American Medical Association, 2007-12, Vol.298 (21), p.2497

2007

Volltextzugriff (PDF)

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

JAMA : the journal of the American Medical Association, 2007-02, Vol.297 (6), p.591

2007

Volltextzugriff (PDF)

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

The American journal of medicine, 2002-07, Vol.113 (1), p.1-6

2002

Volltextzugriff (PDF)

The influence of peripheral arterial disease on outcomes : A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

Journal of the American College of Cardiology, 2006-10, Vol.48 (8), p.1567-1572

2006

Volltextzugriff (PDF)

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-05, Vol.51 (18), p.1734-1741

2008

Volltextzugriff (PDF)

Anthracycline-induced cardiotoxicity

Annals of internal medicine, 1996-07, Vol.125 (1), p.47

1996

Volltextzugriff (PDF)

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-09, Vol.52 (10), p.807-814

2008

Volltextzugriff (PDF)

The role of spironolactone in the treatment of patients with refractory hypertension

American journal of hypertension, 2002-04, Vol.15 (4), p.333-339

2002

Volltextzugriff (PDF)

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Circulation (New York, N.Y.), 2001-05, Vol.103 (21), p.2572-2578

2001

Volltextzugriff (PDF)

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Circulation (New York, N.Y.), 1998-12, Vol.98 (25), p.2829-2835

1998

Volltextzugriff (PDF)

Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites

The American journal of cardiology, 2008-02, Vol.101 (4), p.506-509

2008

Volltextzugriff (PDF)

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)

The American journal of cardiology, 2002-11, Vol.90 (9), p.916-921

2002

Volltextzugriff (PDF)

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

The American journal of cardiology, 2004-07, Vol.94 (1), p.30-34

2004

Volltextzugriff (PDF)

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

JAMA : the journal of the American Medical Association, 2002-11, Vol.288 (17), p.2130

2002

Volltextzugriff (PDF)

Abciximab readministration: Results of the reopro readministration registry

Circulation (New York, N.Y.), 2001-08, Vol.104 (8), p.870-875

2001

Volltextzugriff (PDF)

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

The American journal of cardiology, 2006-06, Vol.97 (11), p.1591-1596

2006

Volltextzugriff (PDF)

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

The Lancet (British edition), 2000-12, Vol.356 (9247), p.2037-2044

2000

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(39)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Cardiovascular System & Cardiology
(26)
Cardiac & Cardiovascular Systems
(25)
Female
(25)
Male
(25)
Middle Aged
(23)
Aged
(20)
Angioplasty, Balloon, Coronary
(18)
Pharmacology. Drug Treatments
(16)
Cardiology. Vascular System
(15)
Platelet Aggregation Inhibitors - Therapeutic Use
(15)
Platelet Glycoprotein Gpiib-Iiia Complex - Antagonists & Inhibitors
(15)
Heart
(14)
Treatment Outcome
(14)
Drug Therapy
(13)
Coronary Heart Disease
(11)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bivalirudin for Patients with Acute Coronary Syndromes

Intravenous Platelet Blockade with Cangrelor during PCI

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

The influence of peripheral arterial disease on outcomes : A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Anthracycline-induced cardiotoxicity

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

The role of spironolactone in the treatment of patients with refractory hypertension

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

Abciximab readministration: Results of the reopro readministration registry

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

Aktive Filter

Suchergebnisse filtern